sb 206553 has been researched along with Cerebral Ischemia in 1 studies
SB 206553: a high-affinity 5-HT(2C/2B) antagonist; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawson, LA | 1 |
| Galandak, J | 1 |
| Djali, S | 1 |
1 other study available for sb 206553 and Cerebral Ischemia
| Article | Year |
|---|---|
Attenuation of ischemic efflux of endogenous amino acids by the novel 5-HT(1A)/5-HT(2) receptor ligand adatanserin.
Topics: Amino Acids; Animals; Brain Ischemia; Fluorobenzenes; Hippocampus; In Vitro Techniques; Indoles; Lig | 2002 |